LENSAR, Inc.
LENSAR, Inc. (LNSR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
lnsr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for LENSAR, Inc. (LNSR) measures how much investors pay for each dollar of the company's trailing earnings. LNSR's current PE ratio of 2.32x is calculated by dividing its stock price of $5.60 by its TTM earnings per share of $2.42.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2018 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
LENSAR, Inc.You LNSR | $68M | 2.32x | — | $2.42 |
 Anika Therapeutics, Inc. ANIK | $194M | N/A | — | -$0.76 |
 Accuray Incorporated ARAY | $42M | N/A | — | -$0.02 |
 Anteris Technologies Global Corp. AVR | $344M | N/A | — | -$3.99 |
 Corbus Pharmaceuticals Holdings, Inc. CRBP | $95M | N/A | — | -$5.90 |
 Cardiff Oncology, Inc. CRDF | $103M | N/A | — | -$0.69 |
 MaxCyte, Inc. MXCT | $123M | N/A | — | -$0.42 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.87 | — | |
2024-12-31 FY2024 | — | $-2.73 | — | |
2023-12-31 FY2023 | — | $-1.31 | — | |
2022-12-31 FY2022 | — | $-1.96 | — | |
2021-12-31 FY2021 | — | $-2.09 | — | |
2020-12-31 FY2020 | — | $-1.81 | — | |
2019-12-31 FY2019 | — | $-1.38 | — | |
2018-12-31 FY2018 | — | $-11.77 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for LENSAR, Inc. (LNSR) measures how much investors pay for each dollar of the company's trailing earnings. LNSR's current PE ratio of 2.32x is calculated by dividing its stock price of $5.60 by its TTM earnings per share of $2.42.
Frequently asked questions
LNSR pe ratio · 6 questionsLNSR's current PE ratio is 2.32x as of 2026-06-08, based on a stock price of $5.60 and TTM EPS of $2.42. Data sourced from Financial Modeling Prep via LNSR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · LENSAR, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08